tiprankstipranks
Trending News
More News >
Prostatype Genomics AB (SE:PROGEN)
:PROGEN
Sweden Market

Prostatype Genomics AB (PROGEN) Financial Statements

Compare
0 Followers

Prostatype Genomics AB Financial Overview

Prostatype Genomics AB's market cap is currently kr41.23M. The company's EPS TTM is kr-1.728; its P/E ratio is ―; Prostatype Genomics AB is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 199.00Kkr 1.36Mkr 683.00Kkr 10.00Kkr 683.88K
Gross Profitkr 1.92Mkr 3.73Mkr 683.00Kkr 2.51Mkr -14.20M
Operating Incomekr -40.85Mkr -39.25Mkr -28.69Mkr -15.55Mkr -16.62M
EBITDAkr -37.40Mkr -38.02Mkr -26.79Mkr -15.46Mkr -15.76M
Net Incomekr -41.05Mkr -41.44Mkr -29.09Mkr -15.63Mkr -17.41M
Balance Sheet
Cash & Short-Term Investmentskr 9.42Mkr 2.68Mkr 11.49Mkr 20.33Mkr 15.86M
Total Assetskr 41.97Mkr 49.22Mkr 30.95Mkr 40.20Mkr 33.66M
Total Debtkr 0.00kr 11.67Mkr 867.00Kkr 1.27Mkr 1.47M
Net Debtkr -9.42Mkr 8.98Mkr -3.94Mkr -8.56Mkr -14.40M
Total Liabilitieskr 8.50Mkr 24.55Mkr 4.80Mkr 4.30Mkr 5.37M
Stockholders' Equitykr 33.47Mkr 24.67Mkr 26.15Mkr 35.91Mkr 28.29M
Cash Flow
Free Cash Flowkr -52.57Mkr -37.70Mkr -27.69Mkr -18.58Mkr -14.74M
Operating Cash Flowkr -44.71Mkr -29.14Mkr -27.69Mkr -16.08Mkr -14.71M
Investing Cash Flowkr -8.36Mkr -8.57Mkr 0.00kr -2.50Mkr -3.26M
Financing Cash Flowkr 59.75Mkr 28.91Mkr 18.85Mkr 23.05Mkr 31.14M
Currency in SEK

Prostatype Genomics AB Earnings and Revenue History

Prostatype Genomics AB Debt to Assets

Prostatype Genomics AB Cash Flow

Prostatype Genomics AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis